Healthcare provider profile · identity verified

Anna Dynkin, CNP

Nurse Practitioner · BURLINGTON, MA · NPI 1912676321

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	378	77
Metoprolol Succinate	Metoprolol Succinate	367	60
Amlodipine Besylate	Amlodipine Besylate	225	42
Eliquis	Apixaban	219	35
Lisinopril	Lisinopril	208	44
Omeprazole	Omeprazole	196	42
Gabapentin	Gabapentin	175	30
Torsemide	Torsemide	149	34
Sertraline Hcl	Sertraline Hcl	145	22
Warfarin Sodium	Warfarin Sodium	142	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	133	22
Tamsulosin Hcl	Tamsulosin Hcl	125	23
Famotidine	Famotidine	124	30
Furosemide	Furosemide	122	28
Metformin Hcl	Metformin Hcl	113	19
Escitalopram Oxalate	Escitalopram Oxalate	111	17
Trazodone Hcl	Trazodone Hcl	111	21
Levothyroxine Sodium	Levothyroxine Sodium	107	24
Potassium Chloride	Potassium Chloride	97	11
Metformin Hcl Er	Metformin Hcl	96	16
Pregabalin	Pregabalin	96	13
Fluoxetine Hcl	Fluoxetine Hcl	90	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	87	14
Hydrochlorothiazide	Hydrochlorothiazide	85	suppressed
Losartan Potassium	Losartan Potassium	85	15
Rosuvastatin Calcium	Rosuvastatin Calcium	83	15
Jardiance	Empagliflozin	82	17
Albuterol Sulfate Hfa	Albuterol Sulfate	74	40
Alendronate Sodium	Alendronate Sodium	73	12
Oxycodone Hcl	Oxycodone Hcl	61	39
Carvedilol	Carvedilol	56	14
Citalopram Hbr	Citalopram Hydrobromide	55	12
Prednisone	Prednisone	55	28
Lorazepam	Lorazepam	51	18
Allopurinol	Allopurinol	50	11
Valsartan	Valsartan	50	suppressed
Spironolactone	Spironolactone	49	14
Pravastatin Sodium	Pravastatin Sodium	48	suppressed
Risperidone	Risperidone	48	suppressed
Nystatin	Nystatin	46	24
Ezetimibe	Ezetimibe	45	suppressed
Donepezil Hcl	Donepezil Hcl	44	suppressed
Duloxetine Hcl	Duloxetine Hcl	44	suppressed
Januvia	Sitagliptin Phosphate	43	suppressed
Simvastatin	Simvastatin	43	suppressed
Finasteride	Finasteride	40	11
Memantine Hcl	Memantine Hcl	39	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	38	suppressed
Chlorthalidone	Chlorthalidone	38	suppressed
Montelukast Sodium	Montelukast Sodium	38	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	37	11
Clonazepam	Clonazepam	36	suppressed
Divalproex Sodium	Divalproex Sodium	36	suppressed
Fluticasone Propionate	Fluticasone Propionate	36	18
Lamotrigine	Lamotrigine	36	suppressed
Latanoprost	Latanoprost	36	12
Clozapine	Clozapine	33	suppressed
Mirtazapine	Mirtazapine	33	suppressed
Trulicity	Dulaglutide	32	12
Benztropine Mesylate	Benztropine Mesylate	31	suppressed
Amiodarone Hcl	Amiodarone Hcl	30	suppressed
Eszopiclone	Eszopiclone	29	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Atenolol	Atenolol	28	suppressed
Azithromycin	Azithromycin	28	19
Divalproex Sodium Er	Divalproex Sodium	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Lidocaine	Lidocaine	23	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Loperamide	Loperamide Hcl	22	suppressed
Unifine Pentips	Pen Needle, Diabetic	22	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	21	suppressed
Insulin Degludec Pen (U-100)	Insulin Degludec	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Ketoconazole	Ketoconazole	21	suppressed
Ramelteon	Ramelteon	21	suppressed
Creon	Lipase/Protease/Amylase	20	suppressed
Digoxin	Digoxin	20	suppressed
Haloperidol	Haloperidol	20	suppressed
Metformin Er Osmotic	Metformin Hcl	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	13
Aripiprazole	Aripiprazole	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Ondansetron Odt	Ondansetron	18	11
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Prednisolone Acetate	Prednisolone Acetate	17	suppressed
Topiramate	Topiramate	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Baclofen	Baclofen	16	suppressed
Dronabinol	Dronabinol	16	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	16	suppressed
Ibuprofen	Ibuprofen	16	13
Meloxicam	Meloxicam	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Tiotropium Bromide	Tiotropium Bromide	16	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	15	15
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Lacosamide	Lacosamide	15	suppressed
Methimazole	Methimazole	15	suppressed
Peg-3350 And Electrolytes	Peg3350/Sod Sulf,bicarb,cl/Kcl	15	14
Perphenazine	Perphenazine	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Cardura Xl	Doxazosin Mesylate	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Metformin Er Gastric	Metformin Hcl	13	suppressed
Rhopressa	Netarsudil Mesylate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Lactulose	Lactulose	12	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Invokana	Canagliflozin	11	suppressed
Lamictal	Lamotrigine	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Single Use Swab	Alcohol Antiseptic Pads	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error